Humog Injection (Menotrophin): Fertility Support Therapy | For Ovulation Induction and Reproductive Treatment
Humog Infusion (Menotrophin) is utilized in the treatment of fruitlessness in ladies. It is additionally useful in the treatment of male hypogonadism (postponed adolescence, and low sperm count) and male barrenness. It works by setting the eggs free from the ovary in ladies and by expanding the testosterone level in men.
Humog Injection is a gonadotropin-based hormonal preparation containing Menotropins (Human Menopausal Gonadotropin, hMG), formulated to support controlled stimulation of the ovaries and testes. It contains follicle-stimulating hormone (FSH) and luteinizing hormone (LH) activity and is administered under medical supervision for specific reproductive and fertility-related indications.
The preparation works by supplying gonadotropins that stimulate the development of ovarian follicles and support ovulation in women, while in selected male patients it can promote testicular stimulation and support sperm production when prescribed as part of fertility management.
Pharmacological Profile
| Parameter | Details |
| Active Ingredient | Menotropins (Human Menopausal Gonadotropin) |
| Drug Class | Gonadotropin / Fertility Hormone |
| Dosage Form | Injectable Preparation |
| Hormonal Activity | FSH and LH activity |
| Primary Target | Ovaries and testes |
| Therapeutic Area | Fertility and reproductive medicine |
Mechanism Insights (How It Works)
- Follicular Stimulation
The FSH activity in Humog Injection promotes the growth and maturation of ovarian follicles, supporting the development of eggs during fertility treatment. - Ovulatory Support
LH activity contributes to follicular development and hormonal processes involved in ovulation. Humog may be incorporated into controlled ovarian stimulation protocols according to the fertility specialist’s treatment plan. - Testicular Stimulation
In selected male fertility protocols, gonadotropin therapy can stimulate the testes and support spermatogenesis when appropriate hormonal conditions are present. - Reproductive Hormone Support
By providing FSH and LH activity, the preparation helps regulate specific reproductive processes that may be impaired by inadequate endogenous gonadotropin stimulation.
Administration Guidelines
- Administer only under the supervision of a qualified healthcare professional.
- The dose and treatment schedule depend on the patient's condition and response to therapy.
- Treatment may require monitoring through hormonal assessments and ultrasound examinations.
- Do not self-administer or change the prescribed dose without medical advice.
- Follow the fertility specialist's instructions throughout the treatment cycle.
Clinical Considerations
- Commonly incorporated into medically supervised fertility-treatment protocols.
- May support follicular development and ovulation induction in appropriately selected female patients.
- Can form part of fertility-management protocols for selected male patients.
- Treatment requires individualized dosing and monitoring to reduce the risk of excessive ovarian stimulation.
- The appropriate regimen varies according to the indication, age, reproductive status, and treatment response.
Precautions:
Humog Injection should be administered with caution to ensure safe and effective treatment. Proper medical supervision is recommended, particularly for individuals with underlying health conditions, fertility-related complications, or those undergoing repeated hormonal treatment.
General Precautions
- Use only under the supervision of a qualified healthcare professional
- Follow the prescribed dose and treatment schedule carefully
- Do not self-administer the injection unless specifically instructed
- Inform your doctor about any existing medical conditions or ongoing medications
- Regular monitoring may be required during treatment
Ovarian Function Considerations
- Humog Injection may stimulate ovarian activity during fertility treatment
- Excessive ovarian response can increase the risk of ovarian hyperstimulation syndrome (OHSS)
- Regular ultrasound and hormone monitoring may be recommended
- Report severe abdominal pain, swelling, rapid weight gain, or breathing difficulties promptly
Pregnancy & Breastfeeding
- Humog Injection is generally administered as part of fertility treatment before pregnancy is established
- Inform your doctor if pregnancy occurs or is suspected during treatment
- Consult a healthcare professional before use while breastfeeding
- Use during pregnancy should only be determined by a qualified medical professional
Medical Condition Considerations
- Inform your doctor if you have thyroid, adrenal, liver, kidney, or reproductive health problems
- Patients with a history of blood clots may require additional medical assessment
- Discuss any previous hormone-sensitive conditions before starting treatment
- Keep all scheduled medical appointments for appropriate treatment monitoring
Usage
General Usage Information
Humog Injection contains Human Menopausal Gonadotropin (hMG), a hormonal preparation used as part of fertility treatment to stimulate ovarian follicle development in women and support sperm production in certain men. Its effectiveness depends on the prescribed dose, injection schedule, and regular monitoring by a healthcare professional.
Key Usage Points
✔ Use the injection exactly as prescribed by a fertility specialist
✔ Administer only by the recommended injection route and technique
✔ Follow the treatment schedule carefully without changing the dose yourself
✔ Regular monitoring may be required to assess treatment response
✔ Store and handle the injection according to the product instructions
Uses
Humog Injection is commonly used in fertility treatment protocols for ovarian stimulation in women who have difficulty ovulating and to support the development of multiple follicles. In certain male infertility cases, it may be used as part of hormonal treatment to stimulate sperm production.
How to Use
- Administer by a healthcare professional or as specifically instructed
- Use the prescribed dose at the recommended time
- The treatment schedule varies according to the individual's fertility condition and response
- Women may require ultrasound and hormone monitoring during treatment
- Follow the fertility specialist's instructions throughout the treatment course
Side Effects
General Safety Information
Humog Injection (Human Menopausal Gonadotropin) is generally well tolerated when administered as prescribed. Most side effects are mild and temporary, but their occurrence may vary depending on the individual’s response to treatment and dosage.
Common Side Effects
✔ Headache
✔ Nausea or vomiting
✔ Abdominal pain or bloating
✔ Injection-site pain, redness, or swelling
✔ Breast tenderness
✔ Fatigue or tiredness
These effects are usually mild and may improve as the body adjusts to the treatment.
Serious Side Effects (Rare but Important)
⚠ Seek medical attention if you experience:
- Severe pelvic or abdominal pain
- Significant abdominal swelling or bloating
- Sudden weight gain
- Difficulty breathing
- Reduced urination
- Severe nausea or vomiting
- Signs of an allergic reaction, such as rash, itching, swelling, or breathing difficulty
Risk Factors & Monitoring
- Women receiving fertility treatment may have an increased risk of ovarian hyperstimulation syndrome (OHSS).
- Treatment should be monitored by a qualified fertility specialist.
- Ultrasound examinations and hormone tests may be recommended to monitor ovarian response.
- The risk of multiple pregnancy may increase with gonadotropin treatment.
FAQs
What is Humog Injection used for?
Humog Injection is used for fertility treatment to stimulate the ovaries and support the development of mature eggs. It may also be prescribed as part of assisted reproductive procedures under medical supervision.
How does Humog Injection work in the body?
It contains human menopausal gonadotropin (hMG), which provides hormones that stimulate ovarian follicles and promote egg development. In men, it may support sperm production when prescribed as part of fertility treatment.
Can Humog Injection be used during fertility treatment?
Yes, Humog Injection is commonly administered as part of medically supervised fertility treatment. The dosage and treatment schedule depend on individual fertility needs and response to therapy.
How should I take Humog Injection?
Humog Injection should be administered by a qualified healthcare professional according to the prescribed dosage and schedule. Do not self-administer it unless your doctor has specifically instructed you on the proper technique.
Interactions
General Interaction Overview
Humog Injection (Human Menopausal Gonadotropin) may interact with certain hormonal medicines and treatments that influence reproductive function or ovarian response. These interactions can affect treatment outcomes or increase the risk of complications, so it is important to inform your healthcare provider about all medicines, supplements, and fertility treatments being used.
Commonly Reported Interactions
- Other gonadotropins may produce additive effects on ovarian stimulation
- Clomiphene or similar fertility medicines may alter the response to treatment
- Human chorionic gonadotropin (hCG) may increase ovarian stimulation and the risk of ovarian hyperstimulation
- Hormonal medicines may influence treatment response depending on the fertility protocol
Humog Injection should be administered under medical supervision, particularly when combined with other fertility medicines. Your doctor may adjust the treatment schedule or dosage based on your response and overall health.
It is important to inform your doctor about all medications and supplements you are taking to help minimize potential interactions and support safe, effective treatment.
| Manufacturer | : | Bharat Serum, India |
| Equivalent Brand | : | Menopur |
| Generic Search | : | Menotrophin |
Latest Products
